| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.35 | 3e-25 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.32 | 1e-23 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.34 | 2e-23 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-14 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.33 | 2e-13 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-12 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.23 | 9e-12 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-11 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |